Durham firm makes key hires following series A funding

On the heels of a $30 million fundraising round late last year, Ribometrix has announced a series of high-profile hires to bolster its drug development. The Durham-based company incubated in the Biolabs Space in downtown since 2017 on $7.5 million in seed funding working to create a drug screening platform – specifically for small-molecule therapeutics that target RNA. That work brought in several heavy investment partners in November, includin g M Ventures, Amgen Ventures, Pappas Capital and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news